NUZOLTRI Trademark

Trademark Overview

On Wednesday, September 2, 2020, a trademark application was filed for NUZOLTRI with the United States Patent and Trademark Office. The USPTO has given the NUZOLTRI trademark a serial number of 90154223. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2023. This trademark is owned by JOHNSON & JOHNSON. The NUZOLTRI trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of oncologic diseases
nuzoltri

General Information

Serial Number90154223
Word MarkNUZOLTRI
Filing DateWednesday, September 2, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2021

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of oncologic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, December 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 5, 2022SOU EXTENSION 3 GRANTED
Monday, December 5, 2022SOU EXTENSION 3 FILED
Monday, December 5, 2022TEAS EXTENSION RECEIVED
Monday, October 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2022SOU EXTENSION 2 GRANTED
Tuesday, May 31, 2022SOU EXTENSION 2 FILED
Tuesday, May 31, 2022TEAS EXTENSION RECEIVED
Friday, December 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 1, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 1, 2021SOU EXTENSION 1 FILED
Wednesday, December 1, 2021TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 18, 2021TTAB RELEASE CASE TO TRADEMARKS
Tuesday, May 18, 2021OPPOSITION TERMINATED NO. 999999
Tuesday, May 18, 2021OPPOSITION DISMISSED NO. 999999
Thursday, April 8, 2021OPPOSITION INSTITUTED NO. 999999
Wednesday, March 10, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 7, 2021ASSIGNED TO EXAMINER
Wednesday, October 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 5, 2020NEW APPLICATION ENTERED

Related Keywords

nuzoltri oncologic diseases treatment prevention pharmaceutical preparations human